Nicole Junkermann: Why Healthtech Rewards Patience, October 2026

The slow parts of health technology are the parts that decide whether any of it works. A look at why patience is the field's most undervalued quality, and what it is not.

Health technology is often described as a fast field, and in one narrow sense it is. Ideas appear quickly. What follows them does not. Nicole Junkermann has found that the distance between an idea and a person actually being helped by it is measured in years, and that most of those years are spent on work nobody thinks to describe.

The slow part is the useful part

The unglamorous middle of this field is where the outcome is decided. Something has to be tested in conditions that resemble ordinary life rather than ideal ones. It has to fit around the way people already do things, because a tool that requires everything else to change will simply not be used. It has to keep working on an average day, which is a much harder test than working on a good one.

None of that is interesting to write about, and all of it is the difference between a promising development and a useful one. The design notes keep coming back to the same observation: the details that decide whether something is adopted are almost always small, practical and invisible from the outside.

Trust accrues at its own speed

The other reason for the slowness is that trust cannot be accelerated. People extend it gradually, on evidence, and they withdraw it quickly when something does not behave as described. A field that deals with health is holding people at their least patient and most vulnerable, and it earns confidence one uneventful interaction at a time.

That is not an obstacle to progress. It is the mechanism by which progress becomes real. A development that has been trusted slowly tends to stay trusted, and one that arrives faster than its evidence rarely survives the first ordinary week.

What patience is not

Patience in this context is not the same as delay, and it is certainly not the same as low expectations. It is the willingness to let something be judged on how it performs over time rather than on how well it is described at the start. It is also a matter of sequence: the questions worth asking early are about fit and reach, and the questions about scale come later.

Nicole Junkermann reads the field this way partly because the record supports it. The developments in women's health that turned out to matter were, almost without exception, unremarkable at the point they appeared, and became obvious only in hindsight. The note on women's health technology in October 2026 makes the same case from the other direction.

A season for the long view

Autumn is a reasonable time to practise this. The months ahead will bring a great deal of description and rather less resolution, and the difference between the two is easier to see with a slow habit than a fast one. An hour a week, kept steadily, outlasts any ambitious programme that has to be defended in a busy month.

The reading notes are where that habit is kept, and the glossary is where the vocabulary is held still long enough to be useful. Between them they make the long view a little easier to hold, which is most of what patience turns out to require.

← Back to the blog